MGNX: MacroGenics, Inc. 2019-05-15 17:07:27 MacroGenics Announces Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer - GlobeNewswire
AMGN: Amgen 2019-04-09 15:57:00 FDA Approves EVENITY(TM) (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture - PR Newswire
TLGT: Teligent, Inc. 2019-04-04 08:54:01 Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.1% - GlobeNewswire
AVNS: Avanos Medical, Inc. 2019-04-03 07:00:00 Avanos Medical Announces FDA Clearance for ON-Q* with Bolus - PR Newswire
MGPI: MGP Ingredients, Inc. 2019-03-29 08:01:30 MGP Ingredients Receives FDA Approval of Fibersym® RW and FiberRite® RW as a Dietary Fiber Source - GlobeNewswire
LCI: Lannett Company, Inc. 2019-03-27 06:52:00 Lannett Receives FDA Approval For Aspirin And Extended-Release Dipyridamole Capsules, 25 mg/200 mg - PR Newswire
JAZZ: Jazz Pharmaceuticals plc 2019-03-26 16:13:00 Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness - PR Newswire
ZBH: Zimmer Biomet Holdings, Inc. 2019-03-25 07:00:00 Zimmer Biomet Receives FDA Clearance of ROSA® ONE Spine System for Robotically-Assisted Surgeries - PR Newswire
OPK: OPKO Health, Inc. 2019-03-21 08:00:00 OPKO Announces Positive Topline Results In Phase 2 Diabetes And Obesity Trial - GlobeNewswire
ABT: Abbott 2019-03-14 13:52:00 Abbott Receives FDA Approval for Expanded Indication for MitraClip(TM) Device - PR Newswire
REGN,SNY: Sanofi 2019-03-11 15:45:00 FDA approves Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents - PR Newswire
REGN: Regeneron Pharmaceuticals, Inc. 2019-03-11 15:44:00 FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents - PR Newswire
2019-02-14 08:30:00 Ultragenyx and Kyowa Kirin Announce Positive 64-Week Results for Crysvita® (burosumab) from Phase 3 Study in Children with X-linked Hypophosphatemia (XLH)
GRFS: Grifols 2019-02-07 12:31:00 Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
MYL: Mylan N.V. 2019-01-31 14:59:00 Mylan Announces FDA Approval of Wixela(TM) Inhub(TM) (fluticasone propionate and salmeterol inhalation powder, USP), First Generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder)
ALLO: Allogene Therapeutics, Inc. 2019-01-28 08:30:00 Allogene Therapeutics, in Collaboration with Servier, Announces FDA Clearance of the IND for ALLO-501, an anti-CD19 Allogeneic CAR T (AlloCAR T™) Therapy
RARE: Ultragenyx Pharmaceutical Inc. 2019-01-04 08:30:00 Ultragenyx Announces Positive Topline Results from First Cohort of Phase 1/2 Clinical Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
PFE: Astellas Pharma Inc. 2018-12-20 09:00:00 Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate